Iacoboni G, Navarro V, Sesques P, Rejeski K, Bastos-Oreiro M, Serpenti F, Martin Lopez AA, Iraola-Truchuelo J, Delgado J, Perez A, Guerreiro M, Caballero AC, Martinez-Cibrian N, Luzardo Henriquez H, Sanchez Pina JM, Sancho JM, Ghesquieres H, Mussetti A, Lopez Corral L, Hernani R, Reguera JL, Sureda A, Bosch F, Martin Garcia-Sancho A, Kwon M, Subklewe M, Kuhnl A, Bachy E, Barba P, Villacampa G, Abrisqueta P. Development and validation of the post-CAR prognostic index for large B-cell lymphoma patients after CAR-T progression in third or later line treatment.. Journal of Hematology & Oncology. 2024; 17(1)DOI:10.1186/s13045-024-01608-8. PMID:39468591. IF:(Q/D).

Bailén, R, Iacoboni, G, Delgado, J, López-Corral, L, Hernani-Morales, R, Ortiz-Maldonado, V, Guerreiro, M, Caballero, AC, Guerra-Domínguez, ML, Sánchez-Pina, JM, Peña, M, Torrent, A, Pérez-Martínez, A, Bastos-Oreiro, M, Reguera-Ortega, JL, Martín, A, Hernandez-Boluda, JC, Martínez-Cibrián, N, Sanz, J, Briones, J, Henriquez, HL, Calbacho, M, Mussetti, A, Sancho, JM, Barba, P, Kwon, M. Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO. Transplantation And Cellular Therapy. 2024; 30(10)DOI:10.1016/j.jtct.2024.06.022. PMID:39069076. IF:4.400(Q1/1D).

Spyridonidis, A, Labopin, M, Savani, B, Kulagin, A, Blaise, D, Versluis, J, Sica, S, Raiola, AM, Vydra, J, Choi, G, Rovira, M, Kwon, M, Sanz, J, It la-Remes, M, Borne, PV, Martino, R, Koc, Y, Brissot, E, Nagler, A, Mohty, M, Ciceri, F. THE IMPACT OF INDIVIDUAL COMORBIDITIES ON NRM RISK FOLLOWING PTCY BASED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN ALWP EBMT STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Serrano, JD, Corral, LL, Valc rcel, D, Sierra, J, Ferra-Coll, C, Velazquez, TC, Dom nguez, FM, Le n, RJ, Ortega, JLR, Go i, CB, L pez, EP, Mart nez, AC, Cadenas, IG, Sim n, JAP. DELAYED ADMINISTRATION OF IXAZOMIB AS PROPHYLAXIS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Gagelmann, N, De Witte, M, Peczynski, C, Boreland, W, Broers, A, Jost, E, Kulagin, A, Esquirol, A, Sica, S, Kuball, J, Byrne, J, Bethge, W, Maertens, J, St lzel, F, Forcade, E, Collin, M, Parma, M, Choi, G, Kr ger, N, Corradini, P, Finazzi, MC, Corral, L, Villar, S, Mussetti, A, Bloor, A, Ladetto, M, Schoemans, H, Penack, O, Moiseev, I, Peric, Z. DARATUMUMAB FOR PURE RED CELL APLASIA AFTER HEMATOPOIETIC CELL TRANSPLANTATION: A STUDY FROM THE TRANSPLANT COMPLICATIONS WORKING PARTY OF EBMT. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

G mez, VE, Corral, LL, Mahillo, BA, Mellado, PA, Dom nguez, FMM, G mez, MA, Cant , PA, G mez, JM, Ochando, MT, Borrego, AB, Pinedo, LG, Ripa, MTZ, Vicent, MG, Vallejos, AB, Izquierdo, I, Cadenas, IG, Velao, SR, Musseti, A, Giro, EC, Moraleda, PP, Pascual, GO, Sierra, PAG, Garc a, L, Guti rrez, VG, P rez-Sim n, JA. RUXOLITINIB IN ACUTE AND CHRONIC GRAFT-VERSUS-RECEPTOR DISEASE: LONG-TERM REAL-LIFE EXPERIENCE IN A MULTI-CENTRE STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Salas, MQ, Solano, MT, Baile-Gonz lez, M, Acera-G mez, M, Fox, L, del Mar P rez-Artigas, M, Santamar a, A, Quintela-Gonz lez, MDC, S nchez-Salinas, A, Salmer n-Camacho, JM, Illana-Alvaro, V, Abdallahi-Lefdil, Z, Cornago-Navascues, J, Pardo, L, Fern ndez-Luis, S, Vega-Su rez, LP, Villar, S, Beorlegui-Murillo, P, Esquirol, A, Izquierdo-Garc a, I, Gonz lez, SR, Mussetti, A, Lavilla, E, L pez-Marin, J, Cedillo, A, Bento, L, Sureda, A. FRAILTY ASSESSMENT IN ADULTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OUTCOMES. PROSPECTIVE STUDY ON BEHALF OF THE GRUPO ESPANOL DE TRASPLANTE HEMATOPOYETICO Y TERAPIA CELULAR (GETH-TC). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Fern ndez-Barge, T, Dom nguez-Garcia, JJ, Escamilla, MS, Caballer, JS, Chorao, P, Boluda, JCH, Velao, SR, Cadenas, IG, Bufarull, RM, Estefania, RC, Alexandre, IF, Pe a, AG, Garc a, AT, Ruiz, RG, Luis, SF, San Miguel, EMO, Ara jo, MC, Pell n, SGD, Rodr guez, MAB. OUTCOMES OF ALLOGENEIC HAEMATOPOIETIC STEM-CELL TRANSPLANTATION IN MYELOFIBROSIS: A MULTICENTER STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Salas, MQ, Solano, MT, Baile-Gonzalez, M, Acera-G mez, M, Fox, L, Perez-Artigas, MD, Santamar a, A, Quintela-Gonz lez, MD, S nchez-Salinas, A, Salmer n-Camacho, JM, Illana-Alvaro, V, Abdallahi-Lefdil, Z, Cornago-Navascues, J, Pardo, L, Fern ndez-Luis, S, Vega-Su rez, LP, Villar, S, Beorlegui-Murillo, P, Esquirol, A, Izquierdo-Garc a, I, Rodr guez-Gonz lez, S, Mussetti, A, Abuin-Blanco, A, Lopez-Mar n, J, Filarerro, S, Bento, L, Sureda, A. FRAILTY SYNDROME IN ADULTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION. PROSPECTIVE STUDY ON BEHALF OF THE GRUPO ESPANOL DE TRASPLANTE HEMATOPOYETICO Y TERAPIA CELULAR (GETH-CT). BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Bobes, A, Tormo, M, Diaz-Beya, M, Beneit, P, Botella, C, Moreno, AF, Mayol, AS, Sangerman, MA, Bermejo, AY, Amigo, MD, Labrador, J, Guinon, AG, Garrido, A, Serrano, J, Polo, SV, Fortes, MG, Sayas, MJ, Bergua, JM, Olave, MT, Vall-Llovera, F, Bargay, J, Sanchez, MP, Boyero, RG, Diaz-Lopez, A, de la Fuente, A. Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study. Clinical Lymphoma Myeloma & Leukemia. 2024; 24DOI:. PMID:. IF:2.700(Q2/4D).

Montoro, J, Ngoya, M, Kulagin, A, Giebel, S, Broers, AEC, Bramanti, S, Halahleh, K, Pérez-Simón, JA, Solano, C, Ozcelik, T, Blaise, D, Sanz, J, Henriques, M, de Latour, RP, Martino, R, Scheid, C, Fox, L, Gromek, T, Jurado, M, Sakellari, I, Van Gorkom, G, Matteucci, P, Nagler, A, Koc, Y, Glass, B. PTCy vs CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT. Blood Advances. 2024; 8(15)DOI:10.1182/bloodadvances.2024013328. PMID:38810260. IF:7.100(Q1/2D).

Medrano-Martorell, S, Capellades, J, Jimenez-Conde, J, Gonzalez-Ortiz, S, Vilas-Gonzalez, M, Rodriguez-Campello, A, Ois, A, Cuadrado-Godia, E, Avellaneda, C, Fernandez, I, Merino-Pena, E, Roquer, J, Marti-Fabregas, J, Giralt-Steinhauer, E. Risk factors analysis according to regional distribution of white matter hyperintensities in a stroke cohort. EUROPEAN RADIOLOGY. 2022; 32(1)DOI:10.1007/s00330-021-08106-2. PMID:34117555. IF:5.900(Q1/2D).

Flores, A, Sero, L, Gomez-Choco, M, Ustrell, X, Pellise, A, Vinas, J, Rodriguez, P, Monterde, A, Castilho, G, Rubiera, M, Amaro, S, Padros, MAF, Cardona, P, Marti-Fabregas, J, Molina, CA, Serena, J, Jimenez-Fabrega, FX, Purroy, F, Zaragoza-Brunet, J, Cocho, D, Palomeras, E, Kuprinski, J, Mas, N, Hernandez-Perez, M, Sanjurjo, E, Carrion, D, Costa, X, Barcelo, M, Monedero, J, Catena, E, Rybyeba, M, Diaz, G, de la Ossa, NP, Ribo, M. The Role of Vascular Imaging atReferral Centers in the Drip and Ship Paradigm. Journal of Stroke & Cerebrovascular Diseases. 2022; 31(1)DOI:10.1016/j.jstrokecerebrovasdis.2021.106209. PMID:34794029. IF:2.500(Q3/7D).

Scholkmann, F, Fischer, JB, Frisk, LK, Delgado-Mederos, R, Mayos, M, Highton, D, Wolf, U, Wolf, M, Durduran, T. Influence of study design on effects of mask wearing on fMRI BOLD contrast and systemic physiology - A comment on Law et al. (2021). NEUROIMAGE. 2021; 244DOI:10.1016/j.neuroimage.2021.118549. PMID:34508896. IF:7.400(Q1/2D).

Guisado-Alonso, D, Edo, MC, Alarcon, PVE, Garcia-Sanchez, SM, Font, MA, Romo, LM, Marrero-Gonzalez, P, Mengual, JJ, Castrillo, L, Montull, C, Corominas, H, Gomez-Choco, M. Progression of Large Vessel Disease in Patients With Giant Cell Arteritis-Associated Ischemic Stroke: The Role of Vascular Imaging A Case Series. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY. 2021; 27(8)DOI:10.1097/RHU.0000000000001498. PMID:32732523. IF:3.902(Q3/6D).

van Kammen, MS, de Sousa, DA, Poli, S, Cordonnier, C, Heldner, MR, van de Munckhof, A, Krzywicka, K, van Haaps, T, Ciccone, A, Middeldorp, S, Levi, MM, Hovinga, JAK, Silvis, S, Hiltunen, S, Mansour, M, Arauz, A, Barboza, MA, Field, TS, Tsivgoulis, G, Nagel, S, Lindgren, E, Tatlisumak, T, Jood, K, Putaala, J, Ferro, JM, Arnold, M, Coutinho, JM, Guisado-Alonso D., Cerebral Venous Sinus Thrombosis T. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. JAMA Neurology. 2021; 78(11)DOI:10.1001/jamaneurol.2021.3619. PMID:34581763. IF:29.907(Q1/1D).

Fischer, JB, Frisk, LK, Scholkmann, F, Delgado-Mederos, R, Mayos, M, Durduran, T. Cerebral and systemic physiological effects of wearing face masks in adults. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021; 118(41)DOI:10.1073/pnas.2109111118. PMID:34607955. IF:12.779(Q1/2D).

Terceno, M, Silva, Y, Bashir, S, Vera-Monge, VA, Cardona, P, Molina, C, Chamorro, A, de la Ossa, NP, Hernandez-Perez, M, Werner, M, Camps-Renom, P, Rodriguez-Campello, A, Canovas, D, Purroy, F, Serena, J. Impact of general anesthesia on posterior circulation large vessel occlusions after endovascular thrombectomy. International Journal of Stroke. 2021; 16(7)DOI:10.1177/1747493020976247. PMID:33573525. IF:6.948(Q1/2D).

Steiner, T, Dichgans, M, Norrving, B, Aamodt, AH, Berge, E, Christensen, H, Fuentes, B, Khatri, P, Korompoki, E, Marti-Fabregas, J, Quinn, T, Toni, D, Zedde, M, Sacco, S, Turc, G. European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines. European Stroke Journal. 2021; 6(3)DOI:10.1177/23969873211024143. PMID:34746429. IF:5.894(Q1/2D).

Ramos-Pachon, A, Garcia-Tornel, A, Millan, M, Ribo, M, Amaro, S, Cardona, P, Marti-Fabregas, J, Roquer, J, Silva, Y, Ustrell, X, Purroy, F, Gomez-Choco, M, Zaragoza-Brunet, J, Canovas, D, Krupinski, J, Sala, NM, Palomeras, E, Cocho, D, Redondo, L, Repullo, C, Sanjurjo, E, Carrion, D, Lopez, M, Almendros, MC, Barcelo, M, Monedero, J, Catena, E, Rybyeba, M, Diaz, G, Jimenez-Fabrega, X, Sola, S, Hidalgo, V, Pueyo, MJ, de la Ossa, NP, Urra, X. Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia. CEREBROVASCULAR DISEASES. 2021; 50(5)DOI:10.1159/000516309. PMID:34023822. IF:3.104(Q3/6D).